Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3.
about
Nuclear actions of insulin-like growth factor binding protein-3Low expression levels of insulin-like growth factor binding protein-3 are correlated with poor prognosis for patients with hepatocellular carcinomaNimotuzumab abrogates acquired radioresistance of KYSE-150R esophageal cancer cells by inhibiting EGFR signaling and cellular DNA repair.Epidermal growth factor receptor protein overexpression and gene amplification are associated with aggressive biological behaviors of esophageal squamous cell carcinomaNimotuzumab increases the anti-tumor effect of photodynamic therapy in an oral tumor model.Methylation status of IGFBP-3 as a useful clinical tool for deciding on a concomitant radiotherapy.Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma.Effect of postoperative radiotherapy for squamous cell cancer of the breast in a surveillance epidemiology and end results population-based study.Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis.Nimotuzumab combined with radiotherapy for esophageal cancer: preliminary study of a Phase II clinical trial.Investigational therapies targeting the ErbB family in oesophagogastric cancer.Role of insulin-like growth factor-binding proteins in the pathophysiology and tumorigenesis of gastroesophageal cancers.Targeted therapy in esophageal cancer.
P2860
Q28080513-E03CA831-878A-4284-A45F-2289A5724F75Q33685277-EFE09BA6-22DB-4831-A6FD-11BF236139F7Q35142705-354CD9DB-2EEB-4355-BAD4-F78FED5049F8Q35870351-16DF23D1-749C-4B85-A0D7-9DE73BD70766Q35955366-60BEB71C-9730-4004-B774-3419A9E9F100Q36213576-F098A04C-26A1-4F73-84AE-84567C16C77CQ36375970-CA3684A8-BA97-4D71-B01A-366C6B033DD2Q36963075-810E753D-5E67-4818-A0D3-73FC9951A37CQ37269328-FD07C542-F1F4-4E99-BA70-FA7496A5741EQ37302618-8781A13F-86EA-41CC-AB64-025C77D3F633Q38221886-80467A34-2548-4C19-86FA-8255F7083A0DQ38586626-F0A326D0-B7A8-4E85-85FD-54AD04B515E5Q38741042-5E70E70A-7264-4D63-AE2B-73E4CACE28B7
P2860
Nimotuzumab promotes radiosensitivity of EGFR-overexpression esophageal squamous cell carcinoma cells by upregulating IGFBP-3.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Nimotuzumab promotes radiosens ...... cells by upregulating IGFBP-3.
@ast
Nimotuzumab promotes radiosens ...... cells by upregulating IGFBP-3.
@en
type
label
Nimotuzumab promotes radiosens ...... cells by upregulating IGFBP-3.
@ast
Nimotuzumab promotes radiosens ...... cells by upregulating IGFBP-3.
@en
prefLabel
Nimotuzumab promotes radiosens ...... cells by upregulating IGFBP-3.
@ast
Nimotuzumab promotes radiosens ...... cells by upregulating IGFBP-3.
@en
P2093
P2860
P356
P1476
Nimotuzumab promotes radiosens ...... cells by upregulating IGFBP-3.
@en
P2093
Jing-Xian Shen
Meng-Zhong Liu
Mu-Yan Cai
Qiao-Qiao Li
Yi-Ji Liao
P2860
P2888
P356
10.1186/1479-5876-10-249
P577
2012-12-11T00:00:00Z
P5875
P6179
1009612978